Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Small Pharma Inc
(OP:
DMTTF
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Oct 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Small Pharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Small Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25
January 24, 2023
From
Small Pharma Inc.
Via
GlobeNewswire
Comparing Psychedelics' Administration Routes: Are Intramuscular Injections More Effective Than Intravenous?
↗
January 11, 2023
Short-acting psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF) has dosed the first patient in its Phase 1 clinical trial assessing intramuscular (IM) versus intravenous (IV) administration of its...
Via
Benzinga
First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026
January 09, 2023
Study will compare the profile of intramuscular versus intravenous SPL026 administration
From
Small Pharma Inc.
Via
GlobeNewswire
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
↗
December 28, 2022
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Via
Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
↗
December 22, 2022
Short-acting psychedelics biotech company Small Pharma Inc.
Via
Benzinga
Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures New Intellectual Property
December 22, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
↗
December 19, 2022
Psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF) confirmed that the first patient has been dosed in its Phase 1b study assessing the interaction between selective serotonin reuptake inhibitors...
Via
Benzinga
How Certain Psychedelics Produce Brain And Behavior Changes: UCL Leads New Study
↗
December 16, 2022
The University College London (UCL) is conducting a new research project called “Understanding Neuroplasticity Induced by Tryptamines (UNITy)” aimed at assessing brain changes and neuroplasticity...
Via
Benzinga
First Patient Dosed in Small Pharma’s Drug Interaction Study
December 15, 2022
Open-label study will assess the interaction between SSRI antidepressants and SPL026
From
Small Pharma Inc.
Via
GlobeNewswire
Small Pharma To Support University College London Research Project on Neuroplasticity
December 14, 2022
Small Pharma will provide SPL026 for the brain-imaging study, which seeks to explore how psychedelic-induced brain changes impact cognition, behaviour and well-being
From
Small Pharma Inc.
Via
GlobeNewswire
Small Pharma to Participate in Upcoming Canaccord Genuity Investor Symposium
December 08, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Psychedelic Stock Gainers And Losers From November 24, 2022
↗
November 24, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
↗
November 23, 2022
Via
Benzinga
Small Pharma to Participate in November Investor and Healthcare Conferences
November 11, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Psychedelic Stock Gainers And Losers From November 8, 2022
↗
November 08, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14
Via
Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
↗
November 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
↗
November 03, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
↗
November 02, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:
Via
Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
↗
October 31, 2022
Small Pharma Inc.
Via
Benzinga
Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028
October 31, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
↗
October 27, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
↗
October 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
↗
October 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39
Via
Benzinga
Allied, Small Pharma Among Top Psychedelic Movers Of Today
↗
October 21, 2022
GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53
Via
Benzinga
This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More
↗
October 19, 2022
Short-acting psychedelics biotech firm Small Pharma Inc.
Via
Benzinga
Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio
October 19, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Psychedelic Stock Gainers And Losers From October 18, 2022
↗
October 18, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14
Via
Benzinga
Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway
↗
October 18, 2022
Small Pharma Inc. (OTCQB: DMTTF), a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six...
Via
Benzinga
Small Pharma Reports Fiscal Second Quarter 2023 Highlights
October 14, 2022
From
Small Pharma Inc.
Via
GlobeNewswire
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
↗
October 14, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.12% at $0.12
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
